{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:26:36Z","timestamp":1780385196983,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100018955","name":"Leeds Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000288","name":"Royal Society","doi-asserted-by":"publisher","award":["IEC\\R3\\203014"],"award-info":[{"award-number":["IEC\\R3\\203014"]}],"id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["753910\/B19R13527"],"award-info":[{"award-number":["753910\/B19R13527"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018063","name":"Bowel Research UK","doi-asserted-by":"publisher","award":["18SC0001"],"award-info":[{"award-number":["18SC0001"]}],"id":[{"id":"10.13039\/100018063","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Photochem Photobiol Sci"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s43630-024-00575-w","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T11:34:39Z","timestamp":1713267279000},"page":"1067-1075","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The contradictory role of febuxostat in ABCG2 expression and potentiating hypericin-mediated photodynamic therapy in colorectal cancers"],"prefix":"10.1007","volume":"23","author":[{"given":"Aaron","family":"King","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Maisey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica L.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Poulter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Jayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5062-2284","authenticated-orcid":false,"given":"M. Ibrahim","family":"Khot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,16]]},"reference":[{"key":"575_CR1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492","author":"F Bray","year":"2018","unstructured":"Bray, F., et al. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA: A Cancer Journal for Clinicians."},{"key":"575_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32319-0","author":"E Dekker","year":"2019","unstructured":"Dekker, E., et al. (2019). Colorectal cancer. The Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(19)32319-0","journal-title":"The Lancet"},{"key":"575_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19173-2","author":"Y-H Cho","year":"2020","unstructured":"Cho, Y.-H., et al. (2020). 5-FU promotes stemness of colorectal cancer via p53-mediated WNT\/\u03b2-catenin pathway activation. Nature Communications. https:\/\/doi.org\/10.1038\/s41467-020-19173-2","journal-title":"Nature Communications"},{"key":"575_CR4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.4187","author":"M Del Rio","year":"2007","unstructured":"Del Rio, M., et al. (2007). Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan. Journal of Clinical Oncology. https:\/\/doi.org\/10.1200\/JCO.2006.07.4187","journal-title":"Journal of Clinical Oncology"},{"key":"575_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-0116-z","author":"Y-H Xie","year":"2020","unstructured":"Xie, Y.-H., et al. (2020). Comprehensive review of targeted therapy for colorectal cancer. Signal Transduction and Targeted Therapy. https:\/\/doi.org\/10.1038\/s41392-020-0116-z","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"575_CR6","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.1c21655","author":"A Pramanik","year":"2022","unstructured":"Pramanik, A., et al. (2022). Affimer tagged cubosomes: Targeting of carcinoembryonic antigen expressing colorectal cancer cells using In Vitro and In Vivo models. ACS Applied Materials & Interfaces. https:\/\/doi.org\/10.1021\/acsami.1c21655","journal-title":"ACS Applied Materials & Interfaces"},{"key":"575_CR7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.3504","author":"MT Seymour","year":"2019","unstructured":"Seymour, M. T., & Morton, D. (2019). FOxTROT: An international randomised controlled trial in 1052 patients (pts) evaluating neoadjuvant chemotherapy (NAC) for colon cancer. Journal of Clinical Oncology. https:\/\/doi.org\/10.1200\/JCO.2019.37.15_suppl.3504","journal-title":"Journal of Clinical Oncology"},{"key":"575_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13091332","author":"JH Correia","year":"2021","unstructured":"Correia, J. H., et al. (2021). Photodynamic therapy review: Principles, photosensitizers, applications, and future directions. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics13091332","journal-title":"Pharmaceutics"},{"key":"575_CR9","doi-asserted-by":"publisher","DOI":"10.5946\/ce.2013.46.1.24","author":"RR Allison","year":"2013","unstructured":"Allison, R. R., & Moghissi, K. (2013). Photodynamic therapy (PDT): PDT mechanisms. Clinical Endoscopy. https:\/\/doi.org\/10.5946\/ce.2013.46.1.24","journal-title":"Clinical Endoscopy"},{"key":"575_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphotobiol.2009.04.001","author":"CA Robertson","year":"2009","unstructured":"Robertson, C. A., et al. (2009). Photodynamic therapy (PDT): A short review on cellular mechanisms and cancer research applications for PDT. Journal of photochemistry and photobiology. B, Biology. https:\/\/doi.org\/10.1016\/j.jphotobiol.2009.04.001","journal-title":"Journal of photochemistry and photobiology. B, Biology"},{"key":"575_CR11","doi-asserted-by":"publisher","DOI":"10.5114\/ceji.2015.56974","author":"M Wachowska","year":"2015","unstructured":"Wachowska, M., et al. (2015). Immunological aspects of antitumor photodynamic therapy outcome. Central European Journal of Immunology. https:\/\/doi.org\/10.5114\/ceji.2015.56974","journal-title":"Central European Journal of Immunology"},{"key":"575_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/php.13253","author":"R Falk-Mahapatra","year":"2020","unstructured":"Falk-Mahapatra, R., & Gollnick, S. O. (2020). Photodynamic therapy and immunity: An update. Photochemistry and Photobiology. https:\/\/doi.org\/10.1111\/php.13253","journal-title":"Photochemistry and Photobiology"},{"key":"575_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154356","author":"N Choudhary","year":"2022","unstructured":"Choudhary, N., et al. (2022). Hypericin and its anticancer effects: From mechanism of action to potential therapeutic application. Phytomedicine. https:\/\/doi.org\/10.1016\/j.phymed.2022.154356","journal-title":"Phytomedicine"},{"key":"575_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2018.06.027","author":"MI Khot","year":"2018","unstructured":"Khot, M. I., et al. (2018). Inhibiting ABCG2 could potentially enhance the efficacy of hypericin-mediated photodynamic therapy in spheroidal cell models of colorectal cancer. Photodiagnosis and Photodynamic Therapy. https:\/\/doi.org\/10.1016\/j.pdpdt.2018.06.027","journal-title":"Photodiagnosis and Photodynamic Therapy"},{"key":"575_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29878-1","author":"WS Kim","year":"2022","unstructured":"Kim, W. S., et al. (2022). AI-enabled, implantable, multichannel wireless telemetry for photodynamic therapy. Nature Communications. https:\/\/doi.org\/10.1038\/s41467-022-29878-1","journal-title":"Nature Communications"},{"key":"575_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2019.10.014","author":"MI Khot","year":"2020","unstructured":"Khot, M. I., et al. (2020). The role of ABCG2 in modulating responses to anti-cancer photodynamic therapy. Photodiagnosis and Photodynamic Therapy. https:\/\/doi.org\/10.1016\/j.pdpdt.2019.10.014","journal-title":"Photodiagnosis and Photodynamic Therapy"},{"key":"575_CR17","doi-asserted-by":"publisher","DOI":"10.1039\/b9pp00086k","author":"R Jendzelovsky","year":"2009","unstructured":"Jendzelovsky, R., et al. (2009). Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells. Photochemical & Photobiological Sciences. https:\/\/doi.org\/10.1039\/b9pp00086k","journal-title":"Photochemical & Photobiological Sciences"},{"key":"575_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72952-1","author":"MI Khot","year":"2020","unstructured":"Khot, M. I., et al. (2020). Characterising a PDMS based 3D cell culturing microfluidic platform for screening chemotherapeutic drug cytotoxic activity. Scientific Reports. https:\/\/doi.org\/10.1038\/s41598-020-72952-1","journal-title":"Scientific Reports"},{"key":"575_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2012.10.003","author":"S Breslin","year":"2013","unstructured":"Breslin, S., & O\u2019Driscoll, L. (2013). Three-dimensional cell culture: The missing link in drug discovery. Drug Discovery Today. https:\/\/doi.org\/10.1016\/j.drudis.2012.10.003","journal-title":"Drug Discovery Today"},{"key":"575_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/srep19103","author":"M Zanoni","year":"2016","unstructured":"Zanoni, M., et al. (2016). 3D tumor spheroid models for in vitro therapeutic screening: A systematic approach to enhance the biological relevance of data obtained. Scientific Reports. https:\/\/doi.org\/10.1038\/srep19103","journal-title":"Scientific Reports"},{"key":"575_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00208","author":"Y Toyoda","year":"2019","unstructured":"Toyoda, Y., et al. (2019). Inhibitors of Human ABCG2: From technical background to recent updates with clinical implications. Frontiers in Pharmacology. https:\/\/doi.org\/10.3389\/fphar.2019.00208","journal-title":"Frontiers in Pharmacology"},{"key":"575_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00518","author":"H Miyata","year":"2016","unstructured":"Miyata, H., et al. (2016). Identification of febuxostat as a new strong ABCG2 inhibitor: Potential applications and risks in clinical situations. Frontiers in Pharmacology. https:\/\/doi.org\/10.3389\/fphar.2016.00518","journal-title":"Frontiers in Pharmacology"},{"key":"575_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2019.00081","author":"SW Cramer","year":"2020","unstructured":"Cramer, S. W., & Chen, C. C. (2020). Photodynamic therapy for the treatment of glioblastoma. Frontiers in Surgery. https:\/\/doi.org\/10.3389\/fsurg.2019.00081","journal-title":"Frontiers in Surgery"},{"key":"575_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci8120203","author":"RE Kast","year":"2018","unstructured":"Kast, R. E., et al. (2018). Augmentation of 5-aminolevulinic acid treatment of glioblastoma by adding ciprofloxacin, deferiprone, 5-fluorouracil and febuxostat: The CAALA regimen. Brain Sciences. https:\/\/doi.org\/10.3390\/brainsci8120203","journal-title":"Brain Sciences"},{"key":"575_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114346","author":"IF Zattoni","year":"2022","unstructured":"Zattoni, I. F., et al. (2022). Targeting breast cancer resistance protein (BCRP\/ABCG2): Functional inhibitors and expression modulators. European Journal of Medicinal Chemistry. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114346","journal-title":"European Journal of Medicinal Chemistry"},{"key":"575_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173631","author":"AM Abdel-Aziz","year":"2020","unstructured":"Abdel-Aziz, A. M., et al. (2020). Amelioration of testosterone-induced benign prostatic hyperplasia using febuxostat in rats: The role of VEGF\/TGF\u03b2 and iNOS\/COX-2. European Journal of Pharmacology. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173631","journal-title":"European Journal of Pharmacology"},{"key":"575_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20030","author":"G Englund","year":"2007","unstructured":"Englund, G., et al. (2007). Efflux transporters in ulcerative colitis: Decreased expression of BCRP (ABCG2) and Pgp (ABCB1). Inflammatory Bowel Diseases. https:\/\/doi.org\/10.1002\/ibd.20030","journal-title":"Inflammatory Bowel Diseases"},{"key":"575_CR28","doi-asserted-by":"publisher","DOI":"10.1159\/000179361","author":"H Gutmann","year":"2008","unstructured":"Gutmann, H., et al. (2008). Breast cancer resistance protein and P-glycoprotein expression in patients with newly diagnosed and therapy-refractory ulcerative colitis compared with healthy controls. Digestion. https:\/\/doi.org\/10.1159\/000179361","journal-title":"Digestion"},{"key":"575_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-021-03901-y","author":"S Kukal","year":"2021","unstructured":"Kukal, S., et al. (2021). Multidrug efflux transporter ABCG2: Expression and regulation. Cellular and Molecular Life Sciences. https:\/\/doi.org\/10.1007\/s00018-021-03901-y","journal-title":"Cellular and Molecular Life Sciences"},{"key":"575_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.863107","author":"L Tan","year":"2022","unstructured":"Tan, L., et al. (2022). The role of photodynamic therapy in triggering cell death and facilitating antitumor immunology. Frontiers in Oncology. https:\/\/doi.org\/10.3389\/fonc.2022.863107","journal-title":"Frontiers in Oncology"},{"key":"575_CR31","doi-asserted-by":"publisher","DOI":"10.5732\/cjc.011.10320","author":"T Nakanishi","year":"2012","unstructured":"Nakanishi, T., & Ross, D. D. (2012). Breast cancer resistance protein (BCRP\/ABCG2): Its role in multidrug resistance and regulation of its gene expression. Chinese Journal of Cancer. https:\/\/doi.org\/10.5732\/cjc.011.10320","journal-title":"Chinese Journal of Cancer"},{"key":"575_CR32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.26.15665","author":"LA Doyle","year":"1998","unstructured":"Doyle, L. A., et al. (1998). A multidrug resistance transporter from human MCF-7 breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America. https:\/\/doi.org\/10.1073\/pnas.95.26.15665","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"575_CR33","first-page":"8","volume":"59","author":"K Miyake","year":"1999","unstructured":"Miyake, K., et al. (1999). Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: Demonstration of homology to ABC transport genes. Cancer Research, 59(1), 8\u201313.","journal-title":"Cancer Research"},{"issue":"18","key":"575_CR34","first-page":"4559","volume":"59","author":"M Maliepaard","year":"1999","unstructured":"Maliepaard, M., et al. (1999). Overexpression of the BCRP\/MXR\/ABCP gene in a topotecan-selected ovarian tumor cell line. Cancer Research, 59(18), 4559\u20134563.","journal-title":"Cancer Research"},{"issue":"1","key":"575_CR35","first-page":"145","volume":"7","author":"RW Robey","year":"2001","unstructured":"Robey, R. W., et al. (2001). Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr\/BCrp\/ABCP1), in flavopiridol-resistant human breast cancer cells. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 7(1), 145\u2013152.","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"key":"575_CR36","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.4.7.1826","author":"H Burger","year":"2005","unstructured":"Burger, H., et al. (2005). Chronic imatinib mesylate exposure leads to reduced intracellular drug accumulation by induction of the ABCG2 (BCRP) and ABCB1 (MDR1) drug transport pumps. Cancer Biology & Therapy. https:\/\/doi.org\/10.4161\/cbt.4.7.1826","journal-title":"Cancer Biology & Therapy"},{"key":"575_CR37","doi-asserted-by":"publisher","DOI":"10.5492\/wjccm.v4.i2.130","author":"AE Mirrakhimov","year":"2015","unstructured":"Mirrakhimov, A. E., et al. (2015). Tumor lysis syndrome: A clinical review. World Journal of Critical Care Medicine. https:\/\/doi.org\/10.5492\/wjccm.v4.i2.130","journal-title":"World Journal of Critical Care Medicine"},{"issue":"10","key":"575_CR38","first-page":"5845","volume":"37","author":"K Kishimoto","year":"2017","unstructured":"Kishimoto, K., et al. (2017). Febuxostat as a prophylaxis for tumor lysis syndrome in children with hematological malignancies. Anticancer Research, 37(10), 5845\u20135849.","journal-title":"Anticancer Research"},{"key":"575_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12839","author":"I Bellos","year":"2019","unstructured":"Bellos, I., et al. (2019). Febuxostat administration for the prevention of tumour lysis syndrome: A meta-analysis. Journal of Clinical Pharmacy and Therapeutics. https:\/\/doi.org\/10.1111\/jcpt.12839","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"key":"575_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-016-0971-3","author":"K Tamura","year":"2016","unstructured":"Tamura, K., et al. (2016). Efficacy and safety of febuxostat for prevention of tumor lysis syndrome in patients with malignant tumors receiving chemotherapy: A phase III, randomized, multi-center trial comparing febuxostat and allopurinol. International Journal of Clinical Oncology. https:\/\/doi.org\/10.1007\/s10147-016-0971-3","journal-title":"International Journal of Clinical Oncology"}],"container-title":["Photochemical & Photobiological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43630-024-00575-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43630-024-00575-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43630-024-00575-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T09:05:25Z","timestamp":1718615125000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43630-024-00575-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,16]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["575"],"URL":"https:\/\/doi.org\/10.1007\/s43630-024-00575-w","relation":{},"ISSN":["1474-905X","1474-9092"],"issn-type":[{"value":"1474-905X","type":"print"},{"value":"1474-9092","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,16]]},"assertion":[{"value":"28 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}